Reed Jobs's Yosemite closes $350 million fund to make cancer non-lethal
The cancer-focused venture firm, spun out of Emerson Collective in 2023, backs startups and offers scientific grants to scientists
Yosemite, the cancer-focused venture firm founded by Reed Jobs, has closed its second fund at $350 million, the founder told Fortune, as it pursues the goal of making cancer non-lethal rather than curing it.